Search - tctmd.com

Displaying 61 - 80 of 309

Sort: Relevancy | Date

News Daily News

Report Provides Snapshot of Initial Commercial TAVR Experience

Todd Neale

November 30, 2015

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

Presentation TCT 2015

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Presenter: John D. Carroll, Ioanna Kosmidou, Danny Dvir

October 15, 2015

Presentation TCT 2015

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Presenter: Danny Dvir

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

Presentation TCT 2015

FDA-Approved or US IDE Studies: SAPIEN 3 - Technical Specifications and Clinical Trial Results (CE Studies and PARTNER II S3HR and S3i)

Presenter: Ariel Finkelstein, Ganesh Manoharan, Susheel Kodali

October 14, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

Presentation TCT 2015

Closing Remarks

Presenter: Rabin dra Nath Chakraborty, Angela Hoye

October 11, 2015

Presentation TCT 2015

What Actually Happened Afterwards

Presenter: George D. Dangas, Paul Hsien-Li Kao, Mao-Shin Lin

October 11, 2015

Presentation TCT 2015

Left Main Bifurcation PCI: Consensus and Take-home Messages

Presenter: Rabin dra Nath Chakraborty, Angela Hoye

October 11, 2015

Presentation TCT 2015

A Complex NonLeft Main Bifurcation: Function vs Morphology

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Jung-Min Ahn

October 11, 2015

Presentation TCT 2015

Top 10 Lessons for Complication-Free TAVR

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Philippe Généreux

October 11, 2015

Presentation TCT 2015

A Complex Left Main Bifurcation

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Marie-Claude Morice

October 11, 2015

Presentation TCT 2015

Complex Left Main Case 2

Presenter: Rabin dra Nath Chakraborty, Angela Hoye, Prakas Chandra Mandal

October 11, 2015

Presentation TCT 2015

Use of Appropriate CTO Techniques: Chinese Perspectives

Presenter: Run-Lin Gao, Dimitri Karmpaliotis, Bo Xu, Jiyan Chen

October 11, 2015

Presentation TCT 2015

Case 4: Happy Ever After or Not? (TAVR With Persistent AR)

Presenter: George D. Dangas, Paul Hsien-Li Kao, Mao-Shin Lin

October 11, 2015

Advertisement

Report Provides Snapshot of Initial Commercial TAVR Experience

My Takeaways From TCT 2015

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

PARTNER II Valve-in-Valve Registry: Evaluation of a Balloon-Expandable Transcatheter Aortic Valve in Patients With Failed Bioprosthetic Surgical Aortic Valves

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

FDA-Approved or US IDE Studies: SAPIEN 3 - Technical Specifications and Clinical Trial Results (CE Studies and PARTNER II S3HR and S3i)

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

Closing Remarks

What Actually Happened Afterwards

Left Main Bifurcation PCI: Consensus and Take-home Messages

A Complex NonLeft Main Bifurcation: Function vs Morphology

Top 10 Lessons for Complication-Free TAVR

A Complex Left Main Bifurcation

Complex Left Main Case 2

Use of Appropriate CTO Techniques: Chinese Perspectives

Case 4: Happy Ever After or Not? (TAVR With Persistent AR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content